This of Ayurvedic Ashwagandha Bramhi tea helps in boosting health
However, there's no sure-shot remedy, but there is a potent Ayurvedic combination that may help heal the damage, reduce memory decline and reduce stress levels.
Falling back to the basics
Stress, lack of sleep, and cognitive overload can all contribute to memory lapses. However, nature has a powerful remedy to help support cognitive function and improve mental clarity: Brahmi and Ashwagandha tea. These two ancient herbs have been revered in
Ayurvedic medicine
for their cognitive benefits and stress-relieving properties.
Here's why adding this tea to your routine might be a beneficial step toward enhancing your mental sharpness and overall well-being.
What is Brahmi?
Brahmi, also known as Bacopa monnieri, is an herb widely used in traditional Indian medicine for its cognitive-enhancing properties. It is known for its ability to support memory, concentration, and mental clarity. Brahmi contains active compounds called bacosides, which are believed to improve synaptic communication in the brain and protect against oxidative stress.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
When Knee Pain Hits, Start Eating These Foods, and Feel Your Pain Go Away (It's Genius)
12facts.com
Read More
Undo
Studies have shown that Brahmi can enhance cognitive performance, reduce anxiety, and support overall brain health.
What is Ashwagandha?
Ashwagandha (Withania somnifera) is another cornerstone of Ayurvedic medicine, often referred to as Indian ginseng. This adaptogenic herb is celebrated for its ability to help the body adapt to stress, balance cortisol levels, and promote a sense of calm. Ashwagandha's cognitive benefits include improved memory, enhanced learning capabilities, and reduced mental fatigue.
Its active compounds, such as withanolides, have been shown to have neuroprotective effects and support cognitive function.
Benefits of consuming Brahmi and Ashwagandha Tea
Enhanced cognitive function:
The combination of Brahmi and Ashwagandha offers a synergistic effect on cognitive performance. Brahmi's memory-boosting properties, combined with Ashwagandha's stress-reducing benefits, can help improve focus, concentration, and mental clarity.
Regular consumption may lead to noticeable improvements in learning and memory recall.
Reduced stress and anxiety
Chronic stress and anxiety can impair cognitive function and memory. Ashwagandha's adaptogenic properties help regulate the body's stress response, while Brahmi has calming effects that may help alleviate anxiety. Together, they create a balanced environment for optimal cognitive health.
Improved sleep quality
Quality sleep is crucial for cognitive function and memory consolidation.
Ashwagandha has been shown to promote better sleep by reducing stress and anxiety. By improving sleep quality, this tea can support memory and overall brain health.
Neuroprotective Effects
Both Brahmi and Ashwagandha contain antioxidants that protect brain cells from oxidative damage. This protection helps reduce the risk of cognitive decline and supports long-term brain health.
Support for Mental Clarity
The combined adaptogenic and cognitive-enhancing properties of Brahmi and Ashwagandha can lead to greater mental clarity and focus.
This can be particularly beneficial for individuals facing demanding mental tasks or those seeking to improve their cognitive performance.
How to Prepare Brahmi and Ashwagandha Tea
Preparing Brahmi and Ashwagandha tea is simple and can easily be added to your daily routine. Here's a basic recipe to get you started:
Ingredients:
1 teaspoon Brahmi powder
1 teaspoon Ashwagandha powder
2 cups of water
Honey or lemon
Instructions:
Boil 2 cups of water in a pot.
Add 1 teaspoon of brahmi powder and 1 teaspoon of ashwagandha powder to the boiling water.
Reduce the heat and let it simmer for 5–10 minutes.
Strain the tea into a cup.
Add honey or lemon, if desired, for added flavor.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
7 minutes ago
- The Hindu
RSS arm seeks clarity on draft guidelines on biosimilars
Swadeshi Jagran Manch (SJM), economic wing of the Rashtriya Swayamsewak Sangh (RSS), urged the Central Drugs Standard Control Organisation (CDSCO), the apex drug regulatory authority, to bring more clarity in its draft guidelines to ensure production of high-quality and cost-effective biosimilars in the country. In a letter to the Director General of CDSCO, SJM sought safeguards for the Indian industry from 'international pressures for regulations' that favour multi-national pharma companies. The CDSCO had recently issued the 2025 draft guidelines on similar biologics, also called biosimilars. 'Though the draft guidelines represent a pivotal advancement in making affordable, life-saving biosimilars accessible to millions of Indians suffering from chronic and life-threatening conditions such as cancer, diabetes, and autoimmune disorders it requires more clarity and direction,' the SJM letter reads. The SJM appreciated the draft guidelines for embracing the '3Rs principle' (replacement, reduction, refinement) as it reflects India's commitment to ethical scientific practices and alignment with global standards for animal welfare. Modern technologies, including in-vitro assays, organ-on-chip models, and computational simulations, provide robust, accurate, and humane alternatives to confirm the safety and biosimilarity of these drugs, it said. 'These methods are often faster and more precise than animal studies, reducing both ethical concerns and development costs,' it added. The organisation, however, noted that the guidelines stipulating that it will be the discretion of the CDSCO to decide whether a requirement of 'additional non-clinical in vivo animal studies' should be waived or not, poses a 'risk' of increasing biosimilar development cost. This provision goes against the practices of the leading regulatory authorities in other countries, it added. 'Prominent regulatory authorities like the UK MHRA, European Medicine Agency (EMA) Health Canada, and USFDA have either eliminated or phased out mandatory animal testing for biosimilars,' SJM said, adding its recommendation that waiving animal studies entirely when comprehensive laboratory tests demonstrate high similarity between a biosimilar and its reference product. Recently, civil societies, in a letter to CDSCO on the draft guidelines on biosimilars, has urged that there is an urgent need to eliminate unnecessary animal studies, and establish clear conditions for requiring comparative clinical trials for affordable biosimilars without compromising safety and efficacy. According to the SJM, the draft guidelines' provision to waive certain clinical trials when biosimilarity is established through analytical and functional studies is a forward-thinking measure, saying this approach can significantly reduce development costs and expedite market entry, which is critical for patients awaiting affordable treatments. However, the lack of explicit criteria in the guidelines for when waivers are permitted introduces ambiguity, potentially leading to inconsistent application and delays as well as 'room for corrupt practices', it said, stressing the need to establish 'clear conditions' for conduct of clinical trials.
Time of India
21 minutes ago
- Time of India
Govt intensifies control measures, as state reports over 650 dengue cases
1 2 Bhubaneswar: The state has reported over 650 dengue cases, including more than 200 cases in Bhubaneswar, since Jan 1, prompting the govt to intensify both active and passive surveillance efforts to curb the spread of the vector-borne disease, officials said. Dr Nilakantha Mishra, director of public health, said Malkangiri and Cuttack followed Bhubaneswar with 60 and 50 cases, respectively. Mishra said that out of 50,000 dengue tests conducted this year, over 650 returned positive. "This year, we observed a decrease in dengue cases compared to last year's 1,080 recorded till July last week," he said. The Integrated Disease Surveillance Programme (IDSP) is actively analysing the situation across various areas to implement necessary control measures. With the capital city recording the highest number of dengue cases, Bhubaneswar Municipal Corporation (BMC) and health teams have ramped up efforts to control the situation. Official sources said Patia, Sikharchandi and Prasanti Vihar are the primary areas reporting new cases. In response, BMC is working to eliminate breeding grounds for Aedes mosquitoes, the carrier of dengue virus. Health teams are also engaging in community outreach to educate residents about dengue prevention. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like TV providers are furious: this gadget gives you access to all channels Techno Mag Learn More Undo They are urging people to avoid storing water in and around their homes, as stagnant water serves as mosquito breeding ground. These efforts are part of a broader strategy to mitigate the impact of dengue and protect public health. "As the state continues to battle the seasonal surge in dengue cases, authorities remain vigilant, employing a combination of surveillance, community engagement and mosquito control measures to safeguard citizens," said the officer. Last year, dengue cases were reported in Balasore, Khurda and Sundargarh districts. Therefore, the govt has taken steps for extensive public awareness, diagnosis and treatment for the prevention and control of malaria and dengue cases. Emphasis was also placed on creating widespread public awareness through information, education and communication measures to prevent the diseases.
Time of India
21 minutes ago
- Time of India
Fertility racket: Docs warn against misleading advices, call for practical approach
Hyderabad: Doctors and experts in the city acknowledge that while the declining fertility rate is a well-established fact, many practical solutions for conception are being overlooked due to misleading advice. This has resulted in recent fraud cases involving the Srushti Fertility Centre. They emphasise that common issues, such as urinary tract infections (UTIs) in men, can negatively impact sperm count. However, instead of addressing these basic issues, patients are often led to explore costly options that ultimately fail. The anxiety faced by many couples is being exploited, pushing them towards illegal treatments that are often ineffective. According to Dr Shivaraj Manoharan, andrologist, urologist, and male fertility consultant at KIMS Kondapur, societal biases often lead to overlooking male factors in women's infertility diagnoses. "Since 1983, the average sperm count has declined from 40 million to 20 million per millilitre, close to the 15 million threshold for fertility. When couples seek fertility help, initial tests mainly focus on women, neglecting male factors and simple infections in the reproductive systems. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Up to 70% off | Libas Purple Days Sale Libas Undo By then, it's often too late," he said. You Can Also Check: Hyderabad AQI | Weather in Hyderabad | Bank Holidays in Hyderabad | Public Holidays in Hyderabad He also noted that simple medications can treat infections in both men and women, allowing them to conceive. Often, the DNA Fragmentation Index in men is overlooked, which can actually gauge the possibilities of fertility. Another crucial factor, yet frequently ignored before pursuing fertility treatments, is stress. Dr M Saradhi Goud, a consultant psychiatrist at Kamineni Hospital, states, "In modern-day lifestyle, stress is a key reason why women are unable to conceive. Stress affects both men and women, contributing to this issue. Often, people approach us too late for stress management, but it is better to understand stress levels and seek help accordingly before pursuing any fertility assistance. " Relationship issues also cause stress; it is important to seek counselling instead of running around for costly treatments, he added. Dr Jyothy Reddy, a fertility specialist at Shreya Hospital, advises couples to seek a second opinion to avoid suggestive or potentially exploitative advice. She warned that delayed diagnosis can lead women to reach an age where conception becomes hindered by a lack of necessary egg production.
